Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential Use of Extracellular Vesicles for the HER2 Status Assessment in Breast Cancer Patients

1 Oct 2024

Abstract excerpt

Human epithelial growth factor receptor 2 (HER2)-targeted therapies are effective in patients with HER2-positive breast cancer. Recent advances have shown that HER2-targeted therapies can also be of benefit when treating tumors expressing low levels of HER2, highlighting the importance of identifying the HER2-low subgroup. This clinical trend has opened new therapeutic avenues for patients who were previously...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Adhesion Molecules Research
Share to Extracellular vesicles in disease
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39412368
DOI: 10.1002/gcc.23264

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential Use of Extracellular Vesicles for the HER2 Status Assessment in Breast Cancer PatientsPMID 39412368Read ↗

Integrating extracellular vesicle and circulating cell-free DNA analysis on a single plasma aliquot from breast cancer patients improves the detection of HER2 positivitySemantic proximity Read ↗

Early Detection and Investigation of Extracellular Vesicles Biomarkers in Breast CancerSemantic proximity Read ↗

Recent advances of small extracellular vesicle biomarkers in breast cancer diagnosis and prognosisSemantic proximity Read ↗

Proteomic profiling of extracellular vesicles allows for human breast cancer subtypingSemantic proximity Read ↗

Digital Profiling of Tumor Extracellular Vesicle-associated RNAs Directly from Unprocessed Blood PlasmaSemantic proximity Read ↗

Exploiting gene expression profiles of circulating extracellular vesicles for breast cancer detectionSemantic proximity Read ↗

Towards establishing extracellular vesicle-associated RNAs as biomarkers for HER2+ breast cancerSemantic proximity Read ↗

Membrane Sensing Peptides -Enhanced SiMoA Platform for the Detection of HER2 on Extracellular Vesicles in Metastatic Breast Cancer PatientsSemantic proximity Read ↗

Molecular Profiling of Endocrine Resistance in HR+/HER2-Metastatic Breast Cancer: Insights from Extracellular Vesicles-Derived DNA and ctDNA in Liquid Biopsies.Semantic proximity Read ↗

Genomic instability-derived plasma extracellular vesicle-microRNA signature as a minimally invasive predictor of risk and unfavorable prognosis in breast cancerSemantic proximity Read ↗

Towards establishing Extracellular Vesicle-associated RNAs as biomarkers for HER2+ breast cancerSemantic proximity Read ↗

Breast Cancer-Derived Extracellular Vesicles: Characterization and Contribution to the Metastatic PhenotypeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.